Molecular Pharmacology, Vol 15, 227-234, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Structural and Stereochemical Requirements for Muscarinic Receptor Binding

¹ Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland 21201 and Department of Biochemical Pharmacology, School of Pharmacy, State University of New York at Buffalo, Buffalo, New York 14241

The ability of stereoisomers of muscarinic agonists and antagonists to inhibit specific [³H](DL)3-quinucidinyl benzilate binding to receptors in rat brain and guinea pig ileum longitudinal muscle is compared to their ability to stimulate or inhibit contraction of the ileum longitudinal muscle. The close correlations observed with receptor antagonists and weak agonists emphasize the equivalence of muscarinic receptors identified by biochemical and physiological techniques. The correlations with the most biologically potent agonists were poor, suggesting high intrinsic activity and large spare receptor populations for these compounds. Muscariic receptors display stereoselectivity with the enantiomers of certain strong agonists in their production of ileum muscle contractions but not in their ability to inhibit [³H](DL)3-quinuclidinyl benzilate binding. Although minor differences are observed between binding stereoselectivity in the muscle and brain tissues, the results suggest a similar structural geometry in the two receptors.

This article has been cited by other articles:

				M. J. Rebecchi and S. N. Pentyala Anaesthetic actions on other targets:protein kinase C and guanine nucleotide-binding proteins Br. J. Anaesth., July 1, 2002; 89(1): 62 - 78. [Abstract] [Full Text] [PDF]